Search - tctmd.com

Displaying 521 - 540 of 1464

Sort: Relevancy | Date

News Conference News TCT 2020

OCT Proves Predictive in Diabetic Patients, Even in FFR-Negative Lesions

Shelley Wood

October 14, 2020

News Conference News EAS 2020

Just One-Third of European Patients Get to LDL Cholesterol Goals

Michael O'Riordan

October 13, 2020

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Conference News EAS 2020

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Michael O'Riordan

October 07, 2020

News Daily News

Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium

L.A. McKeown

October 02, 2020

News Daily News

More Insights Into AAA Genetics Spur New Questions on Screening

Caitlin E. Cox

September 29, 2020

News Daily News

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

Caitlin E. Cox

September 18, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

Multivessel PCI Helps Most in STEMI Patients With Severe Nonculprit Lesions

Todd Neale

September 11, 2020

News Conference News ESC 2020

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Shelley Wood

September 04, 2020

News Daily News

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Michael O'Riordan

September 02, 2020

News Conference News ESC 2020

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

Yael L. Maxwell

September 02, 2020

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

News Conference News ESC 2020

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Yael L. Maxwell

September 01, 2020

News Conference News ESC 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Caitlin E. Cox

August 31, 2020

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

Caitlin E. Cox

August 30, 2020

News Conference News ESC 2020

Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4

Shelley Wood

August 29, 2020

News Daily News

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Yael L. Maxwell

August 27, 2020

News Daily News

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Michael O'Riordan

August 26, 2020

News Daily News

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

Michael O'Riordan

August 25, 2020

Advertisement

OCT Proves Predictive in Diabetic Patients, Even in FFR-Negative Lesions

Just One-Third of European Patients Get to LDL Cholesterol Goals

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium

More Insights Into AAA Genetics Spur New Questions on Screening

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Multivessel PCI Helps Most in STEMI Patients With Severe Nonculprit Lesions

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Trimetazidine Safe but Not Protective Long-term After PCI

Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content